Ongoing Research Efforts and More in Ph+ Acute Lymphoblastic Leukemia

,

OncLive News Network® | <b>Treatment Updates in Ph+ Acute Lymphoblastic Leukemia</b>

Ibrahim T. Aldoss, MD; and Elias Jabbour, MD, discuss ongoing research efforts in the treatment paradigm of Philadelphia chromosome–positive acute lymphoblastic leukemia.